Choksi Laboratories

Choksi Laboratories FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Choksi Laboratories (526546.BO) as of Oct 19, 2026 is -15.86 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 268.57 % — a change of -105.91% (lower).

FCF Conversion

-15.86 %

YoY

-105.91%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Choksi Laboratories is 2026 -15.86 % . FCF Conversion Rate (FCF/EBITDA) of Choksi Laboratories was 2025 268.57 % . It decreases by -105.91% lower compared to the previous year.

The Choksi Laboratories FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
-193.81 INR
Jan 1, 2020
286.42 INR
Jan 1, 2021
84.32 INR
Jan 1, 2022
2,422.61 INR
Jan 1, 2023
127.82 INR
Jan 1, 2024
401.59 INR
Jan 1, 2025
268.57 INR
Jan 1, 2026
-15.86 INR
The Choksi Laboratories FCF Conversion history
YEARFCF ConversionYoY
-15.86 %-105.91%
268.57 %-33.12%
401.59 %+214.17%
127.82 %-94.72%
2,422.61 %+2,772.98%
84.32 %-70.56%
286.42 %-247.78%
-193.81 %-301.06%
96.40 %-57.92%
229.08 %-316.65%
-105.74 %-476.15%
28.11 %-113.48%
-208.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Choksi Laboratories Stock analysis

What does Choksi Laboratories do? Choksi Laboratories Ltd, listed on the Bombay Stock Exchange under ticker 526546.BO with ISIN INE493D01013, is a company based in Indore, India. Founded on June 13, 1994, the company operates within the Industrials sector, specifically in the Professional Services industry. Its primary business involves research, development, and analytical testing for various sectors. Choksi Laboratories provides contract laboratory services, including pharmaceutical analysis, food and beverage analysis, water analysis, and construction material analysis. The company also offers instrument calibration and validation services, covering laboratory and on-site calibration for test equipment, process equipment, and end-user equipment, as well as plant shutdown calibration. Additionally, it delivers environment management services, clinical research, consultancy, and assaying and hallmarking. The firm serves clients across pharmaceuticals, food and agricultural products, construction materials, chemicals, and environmental monitoring. Choksi Laboratories operates under the regulatory requirements of its clients and provides a range of analytical and testing solutions. The company's website is http://www.choksilab.com/. Choksi Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Choksi Laboratories stock

FCF Conversion Rate (FCF/EBITDA) of Choksi Laboratories is -15.86 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Choksi Laboratories changed from 268.57 % to -15.86 %, representing a -105.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Choksi Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Choksi Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Choksi Laboratories

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Choksi Laboratories